Refactory has strategically invested in Bleicher GmbH to enhance lifecycle services in medical technology, particularly in enteral nutrition, while also ensuring smooth succession planning.

Target Information

The Bleicher GmbH is a prominent provider of refurbishment solutions for medical technology, particularly in the field of enteral nutrition. The company is responsible for the complete revitalization and quality assurance of devices used in medical care. These highly specialized services significantly contribute to extending the lifecycle of devices while ensuring the highest standards of safety and quality.

The experienced B2B service provider specializes in the assembly of electromechanical components, cable assembly, and comprehensive lifecycle services. With over 20 years of industry experience, Bleicher GmbH primarily supports clients from the medical technology, manufacturing, automotive, and logistics sectors. Their extensive range of services also includes small series production, repair and maintenance services, and quality assurance for electromechanical components. Additionally, Bleicher takes on responsibilities in procurement, pre-financing, and warehousing to optimally support customers throughout the entire product lifecycle.

With a team of 20 experts, the company manages approximately 900 repairs monthly and has produced over one million components to date. The Bleic

View Source

Similar Deals

Demant KIND

2026

Other Medical Equipment, Supplies & Distribution (NEC) Germany
Janus Henderson Group Plc Medios AG

2025

Other Proprietary & Advanced Pharmaceuticals Germany
Sandoz AG Just – Evotec Biologics

2025

Other Bio Therapeutic Drugs Germany
KARL STORZ Diaspective Vision

2025

Other Medical Imaging Systems Germany
Venrock Healthcare Capital Partners Tubulis

2025

Other Bio Therapeutic Drugs Germany

refactory

invested in

Bleicher GmbH

in 2025

in a Other deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert